Showing 797 results
ADHD drugs could alleviate symptoms of Alzheimer’s
Scientists reviewed 40 years of clinical studies that assessed the effects of NA-targeting drugs, such as certain ADHD drugs, on Alzheimer’s.
AI-developed drug for deadly lung disease reaches phase 2 trials
AI-driven drug development has led to the launch of phase 2 trials of a drug to treat idiopathic pulmonary fibrosis (IPF).
Popular weight-loss drugs show promise as addiction treatments
New trials will test the ability of GLP-1 agonists, a popular class of weight-loss drugs, to help people beat addictions to drugs and alcohol.
What’s next for COVID-19 drugs?
Paxlovid may have underperformed in a new trial, but other promising COVID-19 drugs are being authorized or in the works.
A dietician explains “Zepbound,” the newest weightloss drug
Zepbound recently joined the list of obesity-fighting drugs administered as injections that has been approved by the FDA.
Psychedelic drugs and the law: What’s next?
The push to legalize magic mushrooms, MDMA, LSD, and other hallucinogens is likely to heighten tensions between state and federal law.
Psychoactive drug ibogaine helps veterans with TBI
A small study found that one dose of ibogaine could reduce the symptoms of a traumatic brain injury (TBI) for military vets.
This startup is solving the biggest problem to creating drugs that work
Lab-grown human tissues could revolutionize drug development. This AI-powered robot can create and test 10,000 of them at once.
Radioactive drugs are transforming cancer treatment
Radiopharmaceuticals allow doctors to directly target patients' cancer cells and avoid healthy tissue typically damaged by radiation therapy.
First anti-aging drug for dogs nears approval
The FDA is a major step closer to approving biotech company Loyal's LOY-001, the first anti-aging drug for dogs.
Professor Giles Yeo on making sense of anti-obesity drugs
Anti-obesity drugs have been in the news, and for good reason; they seem to work. Giles Yeo talks us through some misconceptions at play.
“Hydrogel” drugs could suppress HIV with minimal treatments
An injectable solution that self-assembles into a hydrogel to deliver 6 weeks of anti-ARV drugs could make managing HIV less of a burden.
Drugs made in space “cooked real good,” says startup
Varda Space Industries has shared the results of its first mission to manufacture "space drugs" in Earth's orbit.
Octopus tentacle-like patch delivers drugs through your cheek
A needle-free drug delivery system inspired by octopus tentacles could one day replace injections for administering biopharmaceuticals.
Ultrasound waves help Alzheimer’s drug get into the brain
Beaming focused ultrasound waves into the heads of Alzheimer’s patients helped a drug bypass the blood-brain barrier.
HIV drug shows promise against COVID-19 and MERS
Based on promising lab tests, the HIV drug cobicistat could be an effective antiviral treatment for COVID-19.
Weight-loss drug reduces cravings for opioids in small study
A first-of-its-kind trial found that GLP-1 agonists, a popular kind of weight-loss drug, could help people overcome their opioid cravings.
DeepMind’s AI could accelerate drug discovery
A new study suggests that AlphaFold, DeepMind’s AI tool for predicting protein structures, could be useful for drug discovery after all.
New weight loss drug acts like an “exercise pill”
A new candidate weight loss drug called SLU-PP-332 was found to boost muscular and aerobic endurance in mice.
New “Lattice” device tests drugs on eight organs at once
Northwestern University scientists have developed a device that simulates up to eight organs at once to aid drug development.
FDA approves weight-loss drug Wegovy to treat heart problems
The FDA has approved the use of Novo Nordisk’s popular weight-loss drug Wegovy to reduce the risk of certain major heart issues.
Experimental drug cuts heart disease risk factor by 96%
Eli Lilly’s experimental drug lepodisiran reduced blood levels of lipoprotein(a) by up to 96% in a small trial.
Drug for MS may be able to treat Alzheimer’s, too
A drug approved to treat multiple sclerosis reduced neuroinflammation and improved memory in mouse models of Alzheimer’s.
Weight-loss drug cut the risk of heart attack and stroke by 20% in large trial
The weight-loss drug semaglutide reduced patients’ risk of heart attacks, strokes, or death from heart disease by 20% in a large trial.
Cholesterol drug suggests new way to treat Alzheimer’s
A cholesterol drug that reduced brain damage in mice could reveal a new approach to treating Alzheimer’s disease in people.
Brain implant lets cancer patients try 20 different drugs at a time
A microdevice that injects up to 20 drugs into gliomas at once could help doctors quickly identify the best treatment for cancer patients.
AI-discovered drug for ALS enters human trials in just four years
Verge Genomics has begun a trial of their AI-found ALS drug candidate, one of the first tests for this new method of drug discovery.
How do stimulants actually work to reduce ADHD symptoms?
Stimulant drugs are thought to alter the activity of key neuotransmitters, dopamine and noradrenaline, in the brains of people with ADHD.
Weight-loss drug improves heart failure symptoms, too
Novo Nordisk’s popular weight-loss drug semaglutide (Wegovy) improved heart failure symptoms in a trial of more than 500 people.
Is iron the Achilles’ heel for cancer?
Some cancer cells store high quantities of iron. Iron-activated cancer drugs selectively disrupt cancer cells, without harming healthy cells.
Wegovy slashes heart attack risk by 28%
Novo Nordisk’s weight-loss drug Wegovy can reduce a person’s risk of a serious cardiovascular event by 20%.
Lung cancer drug slashes patients’ risk of death by 51%
Osimertinib, an FDA-approved lung cancer drug, slashes the risk of death for certain patients by 51%, according to new trial results.
AI can help predict whether a patient will respond to specific tuberculosis treatments
Instead of a one-size-fits-all treatment approach, AI could help personalize treatments for each patient to provide the best outcomes.
New Alzheimer’s drug slows cognitive decline by 35%
Eli Lilly’s new Alzheimer’s drug, donanemab, slowed cognitive decline by 35% in a phase 3 trial, but two people died from side effects.
Clinical trials can save more lives, and faster, with AI
The type of AI powering ChatGPT could help accelerate drug development by matching patients with clinical trials and vice versa.
Milk could overcome one of the biggest hurdles to RNA therapies
RNA therapies typically break down if administered orally, but particles found in cows’ milk could provide perfect protection.
New drug for fatty liver disease cuts fat by 65%
A new NASH treatment, efruxifermin, significantly reduced liver fat when combined with a GLP-1 drug in a small trial.
Superbug-killing antibiotic is now in human trials
A promising new antibiotic that kills a superbug resistant to nearly all available drugs is now being tested in people.
Drug to grow new teeth heads to human trials
A drug that causes animals to grow new teeth could one day allow us to regenerate teeth lost to injury, disease, or old age.
Cheap drug appears to cut long COVID risk by 41% in small study
The diabetes drug metformin cut COVID-19 patients’ risk of later developing long COVID by 41% in a small study.
Using AI, MIT researchers identify a new class of antibiotic candidates
Using a type of artificial intelligence, MIT researchers have discovered a class of compounds that can kill drug-resistant bacteria.
New drug delivery tech could ensure you never forget your meds
Rice University's new drug delivery tech uses biodegradable microparticles to administer medications exactly when and where they are needed.
Pill version of obesity drug reduced weight almost 13% in new trial
Novo Nordisk has announced positive results for an oral version of the popular weight loss drug sold as Ozempic and Wegovy.
Old drug appears to halt progression of Parkinson’s motor symptoms
A GLP-1 agonist used to treat diabetes appeared to halt the progression of Parkinson’s symptoms in a phase 2 trial.
A simple tweak could improve treatment of a deadly herpes brain infection
Anti-inflammatory drugs could potentially prevent herpes encephalitis from causing permanent brain damage.
ADHD drugs might also treat Alzheimer’s disease
Scientists reviewed 40 years of clinical studies that assessed the effects of NA-targeting drugs, such as certain ADHD drugs, on Alzheimer’s.
T-Minus: Stranded space drugs, a new moon lander, and more
Freethink's weekly countdown of the biggest space news, featuring a stranded space factory, Jeff Bezos' new moon lander, and more.
Existing heart drug may boost treatment for skin cancer
The FDA-approved heart medication ranolazine boosted the efficacy of a BRAF inhibitor in mouse models of melanoma, the deadliest skin cancer.
Cancer med appears to prevent brain aneurysms
Japanese researchers have discovered that the cancer drug sunitinib can prevent the formation of brain aneurysms in mice.
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but AI can help efficiently screen compounds that are lethal to dormant microbes.
Psychedelic inspires discovery of two new drug candidates for depression
Researchers have found ibogaine-inspired compounds effective in treating depression and addiction in mouse models.
Alzheimer’s disease: an illness that needs a long overdue cocktail
Scientists are starting to agree that the "holy grail" solution for Alzheimer's is more likely to be a drug cocktail than a single treatment.
This “bridge” between chemo and cancer solves a big problem for treatment
To improve leukemia treatment, Australian researchers have created a bispecific antibody that connects chemo drugs to cancer cells.
Spread of deadly cancer delayed by organ transplant drug
A groundbreaking discovery on how pancreatic cancer spreads could lead to better therapies for the hard-to-treat disease.
New obesity drug cut weight by 58 pounds in trial, making it the most effective yet
Eli Lilly announced results from a phase 2 clinical trial of the newest entrant in the obesity treatment space.
Cancer treatment is about to get a reboot, thanks to AI
Techniques borrowed from astrophysics are helping to advance personalized cancer treatments beyond what genetics can tell us.
“Brain-eating” amoeba beaten by old European drug
A man infected by a deadly brain-eating amoeba is on the road to recovery thanks to a decades-old drug used to treat urinary tract infections.
New drug could extend lives of people with deadly bone cancer
A new drug might extend the lives of people with bone cancer without subjecting them to painful or unpleasant treatments.
Rapamycin: The unlucky history of the most powerful anti-aging drug
When rapamycin research was revived, it was found to have both anti-cancer and anti-aging properties. Here's what researchers say today.
Cheap liver drug can prevent COVID-19
A cheap, readily available drug used to treat liver disease could also prevent COVID-19 infections — regardless of the variant.
The 5 most exciting clinical trial results of 2023
In 2023, several potentially game-changing meds, including ones to treat pain and high cholesterol, showed huge promise in human trials.
SpaceX successfully launches world’s first “space factory”
SpaceX has successfully deployed a “space factory” developed by startup Varda Space Industries to manufacture drugs in microgravity.
The AI healthcare revolution has begun
The ability of AI to diagnose diseases, discover drugs, and even perform surgery is increasing rapidly — but will patients accept Dr. AI?
Drinking this foam could boost an experimental cancer therapy
A drinkable foam packed with carbon monoxide molecules appears to boost the cancer-killing effects of autophagy inhibitors.
Bad trips: Study examines the long-term adverse effects of psychedelic drugs
New research suggests that some users face long-term difficulties following psychedelic use, including emotional and social challenges.
Molecule reduces inflammation in Alzheimer’s models
A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, improving cognition in tests.
A new hydrogel offers the hope of ending daily injections for diabetes
Type-2 diabetes often involves an intense and exhausting treatment burden, with many injections over many days. That might be set to change.
Ultrasound could help us fight the deadliest cancer
In a small study, Northwestern researchers were able to get chemo drugs into the brains of glioblastoma patients with implanted ultrasound devices.
New drug candidates found in an unlikely place
Costa Rica’s famed sloths harbor bacteria in their fur which can create antibiotic compounds — a potential source of future therapies.
New antiviral shortens COVID-19 by 1.5 days
People taking simnotrelvir, a new antiviral treatment for COVID-19, felt almost immediate symptom relief and got better 1.5 days faster.
New obesity treatments could reshape the world
New obesity treatments, including GLP-1 agonists and gene therapies, could make it easier for people to lose weight and keep it off.
New biomarker test accurately predicts who will respond to antidepressant
Alto Neuroscience’s depression drug seems effective in early trials, a proof-of-concept for biomarker-based design.
Old herpes drug helps kill deadly superbug
The anti-herpes drug edoxudine can weaken the deadly superbug K-pneumoniae, potentially offering a new weapon against antibiotic resistance.
“Living pharmacies” could mean you never forget to take your meds again
The US government is funding the development of "living pharmacies," implants containing cells that release medications on demand.
New non-opioid pain reliever moves closer to approval
Vertex Pharmaceuticals’ new painkiller, VX-548, significantly reduced moderate-to-severe pain in two phase 3 trials.
MIT’s soft fiber implants could offer drug-free pain relief
An innovative new way to use fiber-pulses to inhibit pain.
Breakthrough drug cures sleeping sickness with one dose
A new, one-dose treatment for lethal sleeping sickness was 95% effective at clearing the parasite from patients.
T-Minus: Bezos’ space station advances, Boeing’s capsule crews up, and more
Freethink's weekly countdown of the biggest space news, featuring a new space station, NASA's next astronaut transporter, and more.
Study finds tracking brain waves could reduce post-op complications
Researchers found brain wave signatures that could help determine when patients are transitioning into a deep state of unconsciousness.
Hollow “seed” shrinks cancerous tumors from the inside
A new drug delivery system for pancreatic tumors could dramatically decrease medication dosages, helping minimize unpleasant side effects.
At least 5 people have been cured of HIV. Is the AIDS pandemic ending?
A handful of people have already been functionally cured of HIV — and new, universal cures are just on the horizon.
Tirzepatide: A novel obesity drug ushers in a new era of weight loss — because this one works (Updated)
Patients who received tirzepatide in a recent clinical study lost more than 20% of their body weight (52 pounds, or 23.6 kg).
Something found in bats could help us survive infections and inflammation
This protein may help bats survive viral infections and could be the springboard for new anti-inflammatory drugs.
“Nature’s own Ozempic” or berberine is all over social media
Does berberine work as well as Ozempic to help people lose weight? Social media seems to think so, but it's not likely.
New nasal spray aimed at reversing fentanyl overdoses is now approved
A new overdose-reversing spray that works fast but lasts longer has been approved by the FDA, and will be available by the fall at earliest.
Narcan is now available over-the-counter in the US
Naloxone administered by nasal spray can be a lifesaving drug with minimal side effects. It's now approved for over-the-counter use in the U.S.
First ever therapy for rare genetic disorder now approved
The FDA has approved the first drug for Rett syndrome, a genetic neurodevelopmental disorder, which disproportionately affects women and girls.
New fentanyl vaccine could help avoid relapses and overdoses
An in-development fentanyl vaccine that prevents the drug from entering the brain could one day help people avoid relapsing or overdosing.
Blocking this one protein could strengthen muscles
Stanford researchers have figured out how a therapy that blocks a single protein can reverse age-related muscle loss in mice.
Viruses cause 200+ diseases. This one drug may be able to treat them all.
New Zealand-based startup Kimer Med wants to create an antiviral that would be effective against many known viruses — and unknown.
Breakthrough study discovers that psychedelics breach our neurons
Researchers have discovered that psychedelics can activate 5-HT2A receptors inside of cortical neurons, a possible cause of their therapeutic effects.
New kind of pill cut “bad” cholesterol up to 60% in clinical trial
In a phase 2 trial, a daily oral medication reduced LDL cholesterol levels by up to 60%.
Old Parkinson’s drug helps teens with type 1 diabetes
The Parkinson’s disease drug bromocriptine lowered blood pressure and reduced aortic stiffness in young people with type 1 diabetes.
“I’ve been here before”: DMT study explores a strange memory phenomenon
DMT can induce a sense of profound familiarity, making users feel as if they have entered an alternate reality they have visited before.
Probiotic gut bacteria can produce a vital Parkinson’s drug
L-DOPA is a miraculous Parkinson’s drug with terrible side effects. Researchers have created drug-producing bacteria that may help.
A short history of insomnia and how we became obsessed with sleep
Insomnia is big business and getting bigger. When did sleep become so important, so elusive, and so expensive?
Study suggests that exercise should be prescribed to mental health patients
Researchers concluded that exercise should be prescribed to patients with mental health issues before psychiatric drugs.